ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia
- PMID: 30575675
- DOI: 10.1097/AOG.0000000000003018
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia
Abstract
Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was $2.18 billion ($1.03 billion for women and $1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.
Similar articles
-
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.Obstet Gynecol. 2020 Jun;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891. Obstet Gynecol. 2020. PMID: 32443079
-
ACOG Practice Bulletin No. 202 Summary: Gestational Hypertension and Preeclampsia.Obstet Gynecol. 2019 Jan;133(1):1. doi: 10.1097/AOG.0000000000003019. Obstet Gynecol. 2019. PMID: 30575668
-
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222.Obstet Gynecol. 2020 Jun;135(6):1492-1495. doi: 10.1097/AOG.0000000000003892. Obstet Gynecol. 2020. PMID: 32443077 Review.
-
Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean.Br J Obstet Gynaecol. 1992 Jul;99(7):547-53. doi: 10.1111/j.1471-0528.1992.tb13818.x. Br J Obstet Gynaecol. 1992. PMID: 1525093 Review.
-
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.Obstet Gynecol. 2002 Jan;99(1):159-67. doi: 10.1016/s0029-7844(01)01747-1. Obstet Gynecol. 2002. PMID: 16175681
Cited by
-
Biomarkers for Early Prediction and Management of Preeclampsia: A Comprehensive Review.Med Sci Monit. 2024 May 23;30:e944104. doi: 10.12659/MSM.944104. Med Sci Monit. 2024. PMID: 38781124 Free PMC article. Review.
-
The optimal dosage of aspirin for preventing preeclampsia in high-risk pregnant women: A network meta-analysis of 23 randomized controlled trials.J Clin Hypertens (Greenwich). 2024 May;26(5):455-464. doi: 10.1111/jch.14821. Epub 2024 Apr 29. J Clin Hypertens (Greenwich). 2024. PMID: 38683867 Free PMC article.
-
Changes in Maternal Heart Rate Variability and Photoplethysmography Morphology after Corticosteroid Administration: A Prospective, Observational Study.J Clin Med. 2024 Apr 22;13(8):2442. doi: 10.3390/jcm13082442. J Clin Med. 2024. PMID: 38673715 Free PMC article.
-
Biomarker role of maternal soluble human leukocyte antigen G in pre-eclampsia: A meta-analysis.Immun Inflamm Dis. 2024 Apr;12(4):e1254. doi: 10.1002/iid3.1254. Immun Inflamm Dis. 2024. PMID: 38639563 Free PMC article.
-
Posterior Reversible Encephalopathy Syndrome in a Late Postpartum Patient With a Rare Complication of Subarachnoid Hemorrhage.Cureus. 2024 Mar 12;16(3):e56042. doi: 10.7759/cureus.56042. eCollection 2024 Mar. Cureus. 2024. PMID: 38606256 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical